# Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)

> **NCT00032890** · PHASE3 · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 1588 (—)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** glucosamine
- **DRUG:** chondroitin sulfate
- **DRUG:** glucosamine and chondroitin sulfate combined
- **DRUG:** celecoxib

## Key facts

- **NCT ID:** NCT00032890
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 1588 (—)
- **Last updated:** 2009-01-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032890, "Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00032890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*